Barinthus Biotherapeutics plc ( BRNS) - Stock Earnings
BRNS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -14.6 million USD | — USD |
| 2025Q4 | -11.1 million USD | — USD |
| 2026Q1 | -5.5 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BRNS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -73.3 million USD | 802000 USD |
| 2024 | -61.1 million USD | 15.0 million USD |
| 2025 | -66.6 million USD | — USD |
| 2026 Est. | — | — |
BRNS
Price: $0.66
52 week price:
Earnings Per Share: -1.29 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 26.6 million